Novel phosphate binders: plus ça change, plus c’est la même chose-Reference-Cited by-同舟云学术

Novel phosphate binders: plus ça change, plus c’est la même chose

Published:2014-09 Issue:3 Volume:86 Page:471-474
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Hutchison Alastair J.

Publisher

Elsevier BV

Subject

Nephrology

Reference15 articles.

1. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study;Block;Am J Kidney Dis,1998

2. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. National Kidney Foundation;National Kidney Foundation;Am J Kidney Dis,2003

3. ChartTrends: Bone and Mineral Metabolism in Dialysis (US) 2013,2013

4. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD);Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group;Kidney Int Suppl,2009

5. Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline;Dasgupta;Nephron Clin Pract,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis;BMC Nephrology;2019-02-04

2. Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial;Clinical Journal of the American Society of Nephrology;2017-05-26

3. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification;Expert Opinion on Pharmacotherapy;2016-05-13

4. Cardiovascular mortality in chronic kidney disease patients: potential mechanisms and possibilities of inhibition by resin-based phosphate binders;Expert Review of Cardiovascular Therapy;2015-03-25

5. Neue Arzneimittel 2014;Arzneiverordnungs-Report 2015;2015